Skip to content

Alexia Polissidis

3 papers in the library · 10 citations · publishing 2011-2024

Papers

Sort Most recent Most cited

Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats.

Neuropsychopharmacology December 1, 2024 Charalampos Brakatselos, Alexia Polissidis, George Ntoulas et al. 10 citations

Repeated administration of ketamine (KET) has been used to model schizophrenia-like symptomatology in rodents, but the psychotomimetic neurobiological and neuroanatomical underpinnings remain elusive. In parallel, the unmet need for a better treatment of schizophrenia requires the development of novel therapeutic strategies. Cannabidiol (CBD), a major non-addictive phytocannabinoid has been...

DOI: 10.1038/s41386-024-01977-1 (opens in new tab) Full text (opens in new tab) CBD Schizophrenia treatment Brain research Psychiatric medicine

Detrimental effects of adolescent escalating low-dose Δ9 -tetrahydrocannabinol leads to a specific bio-behavioural profile in adult male rats.

British Journal of Pharmacology April 2021 Nafsika Poulia, Foteini Delis, Charalampos Brakatselos et al.

Adolescent cannabis use is associated with adult psychopathology. When Δ9 -tetrahydrocannabinol (THC), mainly in high doses, is administered to adolescence rats there are also long lasting effects in adults. This study aims to determine the specific adult bio-behavioural profile after adolescent low-dose THC, which better mirrors adolescent recreational cannabis use. Adolescent male...

DOI: 10.1111/bph.15394 (opens in new tab) Full text (opens in new tab) Neurogenesis Adolescent Biochemical pharmacology Cannabinoid +3

Δ(9)-THC and WIN55,212-2 affect brain tissue levels of excitatory amino acids in a phenotype-, compound-, dose-, and region-specific manner.

Behavioural Brain Research October 10, 2011 A Galanopoulos, Alexia Polissidis, Z Papadopoulou-Daifoti et al.

Endocannabinoids are involved in excitatory neurotransmission initiated by glutamate and aspartate. The aim of the present study was to investigate the effects of the cannabinoid agonists, Δ(9)-THC and WIN55,212-2, on tissue (prefrontal cortex, dorsal striatum, nucleus accumbens, hippocampus, amygdala and hypothalamus) levels of glutamate and aspartate in two rat phenotypes, high responders...